19 May 2013
Keywords: biota, benefits, flu, vacc, shortage, potential, crucial
Article | 22 November 2004
A potential shortage of crucial flu vaccines in the USA has boosted Australian biotechnology company Biota. Chiron, which had been ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
22 November 2004
17 May 2013
© 2013 thepharmaletter.com